ReviewAntioxidants & redox signaling2023
Metabolomic Profiles of Human Glioma Inform Patient Survival.
Erratum issuedOpen access · greenAbstract readReview
In one paragraph
Review in Antioxidants & redox signaling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 19 citations in OpenAlex.
- Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growth.Cell · 2026Article
- Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Article
- Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to Chemoradiotherapy.Research square · 2026Article
- Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment.Neuro-oncology · 2026Article
- Integration of omics data in the diagnosis and therapy of glioblastoma.Brain pathology (Zurich, Switzerland) · 2026Review
- Role of lysine acetylation-related genes in the diagnosis and prognosis of glioma.Scientific reports · 2025Article
- From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma.Metabolites · 2025Review
- Oligodendroglioma of the Hippocampus: A Case Report and Systematic Review on Therapeutic Approaches of Oligodendroglioma After WHO 2021 Classification.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Nontargeted metabolomics uncovering metabolite signatures in glioblastoma: a preliminary study on candidate biomarker discovery for IDH subtyping and survival prediction.Frontiers in oncology · 2025Article
- Metabolic profiling of glioblastoma and identification of G0S2 as a metabolic target.Frontiers in oncology · 2025Article
- Unveiling divergent treatment prognoses in IDHwt-GBM subtypes through multiomics clustering: a swift dual MRI-mRNA model for precise subtype prediction.Journal of translational medicine · 2024Article
- Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.Acta neuropathologica · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
29 authors at 6 institutions in 1 country.
Andrew J ScottDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-0835-4888
Luis O CorreaDepartment of Immunology Graduate Program, University of Michigan, Ann Arbor, Michigan, USA.
Donna M EdwardsDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Yilun SunDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Visweswaran RavikumarDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
Anthony C AndrenDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
Li ZhangDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
Sudharsan SrinivasanDepartment of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.
Neil JairathDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Kait VerbalDepartment of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.
Karin MuraszkoDepartment of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.
Oren SagherDepartment of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.
Shannon A CartyDepartment of Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
Shawn Hervey-JumperDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
Daniel OrringerDepartment of Neurosurgery, New York University Langone Health, New York, New York, USA.
Michelle M KimDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Larry JunckDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Yoshie UmemuraDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Denise LeungDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Sriram VennetiDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Sandra Camelo-PiraguaDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Theodore S LawrenceDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Joseph E IppolitoDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, USA.
Wajd N Al-HolouDepartment of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.
Prakash ChinnaiyanDepartment of Radiation Oncology, Beaumont Health, Royal Oak, Michigan, USA.
Jason HethDepartment of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.
Arvind RaoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Costas A LyssiotisDepartment of Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
Daniel R WahlDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan · USCase Western Reserve University · USNYU Langone Health · USOakland University · USUniversity of California, San Francisco · USWashington University in St. Louis · US
Funding
XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2MRESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8MClinical Translation of Stimulated Raman HistologyR01CA226527 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ORRINGER, DANIEL · 2018 to 2025
$4.4MSynthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade GliomasR37CA214955 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KURTEK, SEBASTIAN, RAO, ARVIND · 2018 to 2024
$3.9MProteogenomics of Cancer Training ProgramT32CA140044 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, ARVIND, SARTOR, MAUREEN AGNES · 2010 to 2024
$3.9MTargeting Nucleotide Metabolism to Overcome Therapy Resistance in GlioblastomaR37CA258346 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Daniel R Wahl · 2021 to 2026
$3.3MTargeting metabolic stress to induce pancreatic tumor cell deathR01CA244931 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$1.9MDeveloping therapeutic strategies to elicit metabolic synthetic lethality in glioblastomaR01NS110838 · NINDS · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI CHINNAIYAN, PRAKASH · 2020 to 2024
$1.7MDe Novo Nucleotide Synthesis as a Mediator of Radiation Resistance and a Therapeutic Target in GlioblastomaK08CA234416 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WAHL, DANIEL R · 2019 to 2023
$1.1MCHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISMR00CA218869 · NCI · WASHINGTON UNIVERSITY · PI IPPOLITO, JOSEPH EDWARD · 2018 to 2020
$747kBiologic consequence and therapeuticimplications of cysteine catabolism in glioblastomaR21NS090087 · NINDS · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI CHINNAIYAN, PRAKASH · 2016 to 2017
$418kUnderstanding Sex Disparities in Gliomas Through Sex Differences in Mitochondrial ActivityR21CA242221 · NCI · WASHINGTON UNIVERSITY · PI IPPOLITO, JOSEPH EDWARD · 2019 to 2020
$376kNCI NIH HHS F32 CA260735NCI NIH HHS K08 CA234416NCI NIH HHS K99 CA218869NCI NIH HHS L30 CA209251NCI NIH HHS P30 CA046592NCI NIH HHS R00 CA218869NCI NIH HHS R01 CA226527NCI NIH HHS R01 CA244931NCI NIH HHS R21 CA242221NCI NIH HHS R37 CA214955NCI NIH HHS R37 CA258346NCI NIH HHS T32 CA140044NIAID NIH HHS T32 AI007413NINDS NIH HHS R01 NS110838NINDS NIH HHS R21 NS090087
Abstract
PubMed holds no abstract for this paper.
Indexed as
AstrocytomaBrain NeoplasmsGlioblastomaGliomaHumansIsocitrate DehydrogenaseMutationIsocitrate Dehydrogenase2-hydroxyglutarateastrocytomaglioblastomagliomaIDHmetabolomicsoligodendrogliomaoxidative stressrecurrence
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.